Applied BioCode Corporation (TPE:6598)
Taiwan
· Delayed Price · Currency is TWD 21.95
+0.05 (0.23%)
Apr 29, 2026, 1:30 PM CST
Applied BioCode Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -201.2 | -260.81 | -164.2 | -184.73 | -165.2 | Upgrade
|
| Depreciation & Amortization | 56.14 | 61.16 | 62.4 | 56.12 | 50.62 | Upgrade
|
| Other Amortization | 0.24 | 0.25 | 0.28 | 0.39 | 0.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.92 | - | 0.01 | Upgrade
|
| Stock-Based Compensation | 2.34 | -2.52 | 5.54 | 7.73 | 8.57 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.51 | 0.24 | 0.29 | 0.36 | 5.67 | Upgrade
|
| Change in Accounts Receivable | -77.28 | 5.49 | 19.48 | -3.37 | -24 | Upgrade
|
| Change in Inventory | -2.01 | -26.51 | -78.75 | -25.9 | -13.38 | Upgrade
|
| Change in Accounts Payable | 9.24 | 3.86 | -6.14 | -0.7 | -18.17 | Upgrade
|
| Change in Unearned Revenue | -11.48 | 4.14 | -42.77 | 284.12 | -1.08 | Upgrade
|
| Change in Other Net Operating Assets | -3.14 | 6.98 | -2.14 | 11.85 | 4.86 | Upgrade
|
| Operating Cash Flow | -226.64 | -207.74 | -205.09 | 145.87 | -151.77 | Upgrade
|
| Capital Expenditures | -8.82 | -7.38 | -6.39 | -22.14 | -15.52 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.75 | Upgrade
|
| Investment in Securities | 136.42 | -59.91 | -191.62 | - | - | Upgrade
|
| Other Investing Activities | - | 8.2 | - | - | -0.12 | Upgrade
|
| Investing Cash Flow | 127.6 | -59.09 | -198.02 | -22.14 | -16.39 | Upgrade
|
| Long-Term Debt Repaid | -19.01 | -16.79 | -15.74 | -15.14 | -15.53 | Upgrade
|
| Total Debt Repaid | -19.01 | -16.79 | -15.74 | -15.14 | -15.53 | Upgrade
|
| Net Debt Issued (Repaid) | -19.01 | -16.79 | -15.74 | -15.14 | -15.53 | Upgrade
|
| Issuance of Common Stock | 0.2 | 441.18 | 0.04 | 0.28 | 1.34 | Upgrade
|
| Financing Cash Flow | -18.81 | 424.4 | -15.7 | -14.86 | -14.19 | Upgrade
|
| Foreign Exchange Rate Adjustments | -23.32 | 35.19 | 0.67 | 76.38 | -19.49 | Upgrade
|
| Net Cash Flow | -141.17 | 192.76 | -418.13 | 185.25 | -201.84 | Upgrade
|
| Free Cash Flow | -235.46 | -215.12 | -211.48 | 123.73 | -167.29 | Upgrade
|
| Free Cash Flow Margin | -49.55% | -62.70% | -53.52% | 31.70% | -52.29% | Upgrade
|
| Free Cash Flow Per Share | -2.29 | -2.37 | -2.59 | 1.51 | -2.05 | Upgrade
|
| Cash Interest Paid | 1.59 | 1.43 | 2.17 | 2.78 | 2.87 | Upgrade
|
| Cash Income Tax Paid | 0.08 | 0.03 | 0.76 | 0.02 | 0.02 | Upgrade
|
| Levered Free Cash Flow | -139.57 | -109.98 | -92.54 | -56.4 | -88.19 | Upgrade
|
| Unlevered Free Cash Flow | -138.57 | -109.09 | -91.19 | -54.66 | -86.4 | Upgrade
|
| Change in Working Capital | -84.67 | -6.05 | -110.32 | 266 | -51.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.